Publication:
Stroke prevention in atrial fibrillation: Past, present and future comparing the guidelines and practical decision-making

Simple item page
dc.contributor.authorLip, Gregory Y. H. (57216675273)
dc.contributor.authorFreedman, Ben (35481156500)
dc.contributor.authorde Caterina, Raffaele (7102684371)
dc.contributor.authorPotpara, Tatjana S. (57216792589)
dc.date.accessioned2025-06-12T17:58:59Z
dc.date.available2025-06-12T17:58:59Z
dc.date.issued2017
dc.description.abstractConcepts and our approaches to stroke prevention in atrial fibrillation (AF) have changed markedly over the last decade. There has been an evolution over the approach to stroke and bleeding risk assessment, as well as new treatment options. An increasing awareness of AF has led to calls to improve the detection of and population screening for AF. Stroke and bleeding risk assessment continues to evolve, and the ongoing debate on balance between simplicity and practicality, against precision medicine will continue. In this review article, we provide an overview of past, present and the (likely) future concepts and approaches to stroke prevention in AF. We propose three simple steps (the Birmingham ‘3-step’) that offers a practical management pathway to help streamline and simplify decision-making for stroke prevention in patients with AF. © Schattauer 2017.
dc.identifier.urihttps://doi.org/10.1160/TH16-11-0876
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85021638449&doi=10.1160%2fTH16-11-0876&partnerID=40&md5=3306b93a57ea98c0ab613ab238414944
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/7310
dc.subjectAtrial fibrillation
dc.subjectNon-vitamin K antagonist oral anticoagulants
dc.subjectStroke prevention
dc.subjectWarfarin
dc.titleStroke prevention in atrial fibrillation: Past, present and future comparing the guidelines and practical decision-making
dspace.entity.typePublication

Files

Collections

Publikacije / Publications